AV

Advanced Oncotherapy PLCLSE Advanced Oncotherapy Stock Report

Last reporting period 30 Jun, 2022

Updated —

Last price

Market cap $B

0.013

Micro

Exchange

XLON - London Stock Exchange

AVO.L Stock Analysis

AV

Uncovered

Advanced Oncotherapy PLC is uncovered by Eyestock quantitative analysis.

Market cap $B

0.013

Dividend yield

Shares outstanding

537.48 B

Advanced Oncotherapy Plc engages in the development of proton therapy systems. The firm is focused on developing and supplying technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to the patient's healthy tissues. The firm has developed a particle therapy system, LIGHT system, as a series of modular units. The LIGHT system is a machine, which is used in cancer treatment. The linear design of LIGHT allows for an active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The firm leases its LIGHT system machines to healthcare providers, which enables hospitals and treatment centers to customize cancer treatment plans based on a range of energies. In addition, a dynamic transversal modulation allows a precise three-dimensional (3D) treatment of the tumors through the spot scanning technique.

View Section: Eyestock Rating